EN
HI
Summary
As of 15 Nov, 2026, Gufic Biosciences stock price is ₹473.05. During the trading session, the stock has moved between an intraday low of ₹467.05 and an intraday high of ₹488.90. Over the last 52 weeks, Gufic Biosciences has traded between ₹268.00 and ₹493.95.
The stock has recorded a trading volume of 2,19,503 shares,. Its Average Traded Price (ATP) is ₹476.25, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹473.05.
Gufic Biosciences has an upper circuit limit of ₹567.65 and a lower circuit limit of ₹378.45. The total value traded stands at ₹10.45 CR, and the delivery percentage for the day is 44.78%.
The stock is currently traded with a market lot size of 1. Gufic Biosciences also offers a dividend yield of 0.02%.
Gufic Biosciences Share Price Chart
Gufic Biosciences Share Key Metrics
Volume
2.20 L
Market Cap
4743.86 CR
LTQ@LTP
1@473.05
ATP
476.25
Var Margin
18.65 %
Circuit Range
378.45-567.65
Delivery %
44.78 %
Value
10.45 CR
ASM/GSM
No
Market Lot
1
Gufic Biosciences Fundamentals
P/E Ratio
64.38
P/B Ratio
6.88
Div. Yield
0.02
Sector P/E
41.18
Sector P/B
2.49
Sec. Div. Yield
0.53
Gufic Biosciences Resistance and Support
Pivot 481.93
Resistance
First Resistance
495.06
Second Resistance
503.13
Third Resistance
516.26
Support
First Support
473.86
Second Support
460.73
Third Support
452.66
Gufic Biosciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 487 | 473.05 | -2.86% | 488.9 | 467.05 |
| Thu Nov 12 2026 | 469.79 | 487 | 4.20% | 490 | 468.79 |
| Wed Nov 11 2026 | 480 | 467.35 | -1.48% | 493.95 | 462.6 |
Gufic Biosciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-14 | Quarterly Results |
| 2026-08-14 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results & Others |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Gufic Biosciences News
Gufic Biosciences Ltd - 509079 - Board Meeting Outcome for Meeting Held On Saturday, November 14, 2026
Gufic Biosciences reported Q2 FY27 cons. revenue of ₹289.40 crores and a net profit of ₹23.47 crores, up 39.5% YoY. The board also appointed Dr. Reeta Shah as an Independent Director for a 5-year term effective December 1, 2026.
Nov 14 2026 20:11:03
Gufic Biosciences Ltd - 509079 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Gufic BioSciences received an ITAT order remanding the tax assessment for AY 2023-24 back to the Assessing Officer. The original demand of Rs.11.88 crores had been reduced to Rs.11.76 lakhs by CIT(A), and now the matter will undergo fresh assessment.
Nov 04 2026 18:37:54
Read More
Gufic Biosciences Management
| Name | Position |
|---|---|
| Ami Shah | Company Secretary & Compliance Officer |
| Jayesh P Choksi | Chairman & Managing Director |
Gufic Biosciences Similar Stocks
Sahajanand Medical Technologies Ltd.
533.95
29.30 (5.81%)
Artemis Medicare Services Ltd.
321.80
5.05 (1.59%)
Gujarat Themis Biosyn Ltd.
388.65
1.10 (0.28%)
SMS Pharmaceuticals Ltd.
508.05
-15.80 (3.02%)
Aarti Drugs Ltd.
507.35
-1.40 (0.28%)
RPG Life Sciences Ltd.
2551.30
-51.90 (1.99%)
Kwality Pharmaceuticals Ltd.
3822.60
-126.10 (3.19%)
Indraprastha Medical Corporation Ltd.
330.15
-6.10 (1.81%)
Shukra Medtech Ltd.
82.23
0.03 (0.04%)
Gufic Biosciences FAQs
The Buying Price of Gufic Biosciences share is 473.05 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Gufic Biosciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gufic Biosciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Gufic Biosciences shares is 64.38. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Gufic Biosciences shares is 6.88. Useful to assess the stock's value relative to its book value.
To assess Gufic Biosciences’s valuation compare Sector P/E, P/B which are 41.18 & 2.49 with sector averages, along with growth rates and financial metrics.
The Market Cap of Gufic Biosciences is 4743.86 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Gufic Biosciences share price is 493.95 & 268.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Gufic Biosciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GUFICBIO
